Other
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Morgan Stanley Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation increased by 249.1% to $21.83B in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 5, 2026
Metric ID:
other_cash_cash_equivalents_restricted_cash_and_restrict_8b4577Historical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | -$14.65B | $21.83B |
| QoQ Change | — | +249.1% |
| YoY Change | — | +249.1% |
Range-$14.65B – $21.83B
Avg YoY Growth+249.1%
Median YoY Growth+249.1%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation at Other Companies
Frequently Asked Questions
- What is Morgan Stanley's cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation?
- Morgan Stanley (MS) reported cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation of $21.83B in Q1 2026.